Option Care Health [OPCH] vs DaVita [DVA] Detailed Stock Comparison
Option Care Health
NASDAQ
Loading...
DaVita
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Option Care Health wins in 4 metrics, DaVita wins in 15 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Option Care Health | DaVita | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.81 | 13.55 | DaVita |
| Price-to-Book Ratio | 3.43 | 6.86 | Option Care Health |
| Debt-to-Equity Ratio | 90.35 | 825.19 | Option Care Health |
| PEG Ratio | 22.81 | 5.78 | DaVita |
| EV/EBITDA | 13.85 | 8.87 | DaVita |
| Profit Margin (TTM) | 3.93% | 6.35% | DaVita |
| Operating Margin (TTM) | 5.84% | 15.70% | DaVita |
| EBITDA Margin (TTM) | 5.84% | 15.70% | DaVita |
| Return on Equity | 15.25% | 57.94% | DaVita |
| Return on Assets (TTM) | 6.20% | 7.15% | DaVita |
| Free Cash Flow (TTM) | $287.79M | $1.47B | DaVita |
| 1-Year Return | -9.71% | -8.85% | DaVita |
| Price-to-Sales Ratio (TTM) | 0.87 | 0.75 | DaVita |
| Enterprise Value | $5.54B | $23.84B | DaVita |
| EV/Revenue Ratio | 1.03 | 1.81 | Option Care Health |
| Gross Profit Margin (TTM) | 19.00% | 33.08% | DaVita |
| Revenue per Share (TTM) | $32 | $164 | DaVita |
| Earnings per Share (Diluted) | $1.26 | $10.15 | DaVita |
| Beta (Stock Volatility) | 0.79 | 1.09 | Option Care Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Option Care Health vs DaVita Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Option Care Health | 3.23% | 1.48% | -3.49% | -10.27% | -10.41% | 26.61% |
| DaVita | 2.02% | 3.68% | -3.90% | 1.33% | -1.18% | -6.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Option Care Health | -9.71% | -9.02% | 143.77% | 192.07% | 40.61% | 17.21% |
| DaVita | -8.85% | 58.33% | 61.44% | 83.98% | 328.97% | 530.26% |
Performance & Financial Health Analysis: Option Care Health vs DaVita
| Metric | OPCH | DVA |
|---|---|---|
| Market Information | ||
| Market Cap | $4.66B | $9.84B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,989,663 | 705,370 |
| 90 Day Avg. Volume | 1,736,598 | 824,027 |
| Last Close | $28.74 | $140.36 |
| 52 Week Range | $21.39 - $35.53 | $126.07 - $179.60 |
| % from 52W High | -19.11% | -21.85% |
| All-Time High | $91.80 (Apr 22, 2002) | $179.60 (Jan 27, 2025) |
| % from All-Time High | -68.69% | -21.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.06% |
| Quarterly Earnings Growth | -0.05% | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.06% |
| Operating Margin (TTM) | 0.06% | 0.16% |
| Return on Equity (TTM) | 0.15% | 0.58% |
| Debt to Equity (MRQ) | 90.35 | 825.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.38 | $-4.98 |
| Cash per Share (MRQ) | $1.27 | $10.34 |
| Operating Cash Flow (TTM) | $279.64M | $1.86B |
| Levered Free Cash Flow (TTM) | $194.12M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Option Care Health vs DaVita
| Metric | OPCH | DVA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.81 | 13.55 |
| Forward P/E | 22.81 | 12.21 |
| PEG Ratio | 22.81 | 5.78 |
| Price to Sales (TTM) | 0.87 | 0.75 |
| Price to Book (MRQ) | 3.43 | 6.86 |
| Market Capitalization | ||
| Market Capitalization | $4.66B | $9.84B |
| Enterprise Value | $5.54B | $23.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.03 | 1.81 |
| Enterprise to EBITDA | 13.85 | 8.87 |
| Risk & Other Metrics | ||
| Beta | 0.79 | 1.09 |
| Book Value per Share (MRQ) | $8.38 | $-4.98 |
Financial Statements Comparison: Option Care Health vs DaVita
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OPCH | DVA |
|---|---|---|
| Revenue/Sales | $1.33B | $3.22B |
| Cost of Goods Sold | $1.07B | $2.24B |
| Gross Profit | $263.05M | $983.87M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $79.19M | $433.33M |
| EBITDA | $93.16M | $597.84M |
| Pre-Tax Income | $63.56M | $286.33M |
| Income Tax | $16.81M | $54.12M |
| Net Income (Profit) | $46.74M | $232.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OPCH | DVA |
|---|---|---|
| Cash & Equivalents | $198.82M | $438.78M |
| Total Current Assets | $1.18B | $3.64B |
| Total Current Liabilities | $773.62M | $2.91B |
| Long-Term Debt | $1.20B | $11.72B |
| Total Shareholders Equity | $1.36B | $1.66B |
| Retained Earnings | $766.60M | $1.70B |
| Property, Plant & Equipment | $134.76M | $11.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OPCH | DVA |
|---|---|---|
| Operating Cash Flow | $-46.97M | $287.94M |
| Capital Expenditures | $-9.37M | $-143.26M |
| Free Cash Flow | $-16.59M | $36.75M |
| Debt Repayment | $-1.63M | $-345.97M |
| Common Stock Repurchase | $-100.22M | $-541.85M |
Short Interest & Institutional Ownership Analysis
| Metric | OPCH | DVA |
|---|---|---|
| Shares Short | 4.95M | 6.11M |
| Short Ratio | 3.37 | 8.22 |
| Short % of Float | 0.05% | 0.16% |
| Average Daily Volume (10 Day) | 1,989,663 | 705,370 |
| Average Daily Volume (90 Day) | 1,736,598 | 824,027 |
| Shares Outstanding | 166.26M | 80.54M |
| Float Shares | 152.93M | 35.70M |
| % Held by Insiders | 0.01% | 0.50% |
| % Held by Institutions | 1.02% | 0.52% |
Dividend Analysis & Yield Comparison: Option Care Health vs DaVita
| Metric | OPCH | DVA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |